WO2012119997A1 - Pharmaceutical formulation for producing rapidly disintegrating tablets - Google Patents
Pharmaceutical formulation for producing rapidly disintegrating tablets Download PDFInfo
- Publication number
- WO2012119997A1 WO2012119997A1 PCT/EP2012/053771 EP2012053771W WO2012119997A1 WO 2012119997 A1 WO2012119997 A1 WO 2012119997A1 EP 2012053771 W EP2012053771 W EP 2012053771W WO 2012119997 A1 WO2012119997 A1 WO 2012119997A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- film
- forming
- sugar
- weight
- tablets
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 9
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 61
- 235000000346 sugar Nutrition 0.000 claims abstract description 60
- 239000008187 granular material Substances 0.000 claims abstract description 30
- 150000008163 sugars Chemical class 0.000 claims abstract description 24
- 239000007884 disintegrant Substances 0.000 claims abstract description 18
- 229920000642 polymer Polymers 0.000 claims abstract description 18
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 30
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 29
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 29
- 239000007921 spray Substances 0.000 claims description 29
- 239000002245 particle Substances 0.000 claims description 25
- 238000009472 formulation Methods 0.000 claims description 21
- 230000002776 aggregation Effects 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 15
- 229930195725 Mannitol Natural products 0.000 claims description 15
- 239000000594 mannitol Substances 0.000 claims description 15
- 235000010355 mannitol Nutrition 0.000 claims description 15
- 238000005054 agglomeration Methods 0.000 claims description 14
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 238000005469 granulation Methods 0.000 claims description 10
- 230000003179 granulation Effects 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 8
- 239000011230 binding agent Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000000600 sorbitol Substances 0.000 claims description 8
- 235000010356 sorbitol Nutrition 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 239000004386 Erythritol Substances 0.000 claims description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- 235000019414 erythritol Nutrition 0.000 claims description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 6
- 229940009714 erythritol Drugs 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- 230000036571 hydration Effects 0.000 claims description 5
- 238000006703 hydration reaction Methods 0.000 claims description 5
- 239000000832 lactitol Substances 0.000 claims description 5
- 235000010448 lactitol Nutrition 0.000 claims description 5
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 5
- 229960003451 lactitol Drugs 0.000 claims description 5
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 5
- 239000000845 maltitol Substances 0.000 claims description 5
- 235000010449 maltitol Nutrition 0.000 claims description 5
- 229940035436 maltitol Drugs 0.000 claims description 5
- 229920003176 water-insoluble polymer Polymers 0.000 claims description 5
- 229960001855 mannitol Drugs 0.000 claims description 4
- 239000000049 pigment Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 3
- 239000004097 EU approved flavor enhancer Substances 0.000 claims description 2
- 239000002535 acidifier Substances 0.000 claims description 2
- 229940095602 acidifiers Drugs 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 235000019264 food flavour enhancer Nutrition 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 239000000905 isomalt Substances 0.000 claims description 2
- 235000010439 isomalt Nutrition 0.000 claims description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 239000003570 air Substances 0.000 description 28
- 239000000243 solution Substances 0.000 description 21
- 210000000214 mouth Anatomy 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 235000019325 ethyl cellulose Nutrition 0.000 description 8
- 229920001249 ethyl cellulose Polymers 0.000 description 8
- -1 palatinite Chemical compound 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- 239000001856 Ethyl cellulose Substances 0.000 description 6
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000000314 lubricant Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000012080 ambient air Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000013022 formulation composition Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 2
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000006069 physical mixture Substances 0.000 description 2
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000004886 process control Methods 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 229920001897 terpolymer Polymers 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229920003144 amino alkyl methacrylate copolymer Polymers 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Chemical class 0.000 description 1
- 239000011575 calcium Chemical class 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229960000878 docusate sodium Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 1
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Chemical class 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 239000007967 peppermint flavor Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Chemical class 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Definitions
- the present invention relates to pharmaceutical formulations in the form of granules for the preparation of rapidly disintegrating tablets containing non-film-forming sugars or sugar alcohols, film-forming sugars or sugar alcohols, cross-linked polyvinylpyrrolidone and water-insoluble polymers.
- Rapidly disintegrating in the mouth and / or rapidly dissolving tablets are becoming increasingly important for the oral administration of drugs.
- Such tablets must taste pleasant within a short time, preferably within 30 seconds in the oral cavity, and must not leave a sandy feeling.
- the direct tabletting offers considerable advantages over the wet granulation, and have a high mechanical strength, so they survive packaging procedures, transport and also the squeezing out of packaging unscathed.
- Fast disintegrating tablets often consist of sugars and sugar alcohols, effervescent systems, microcrystalline cellulose and other non-water-soluble fillers such as calcium hydrogen phosphate, cellulose derivatives, corn starch, or polypeptides.
- water-soluble polymers conventional disintegrants (crosslinked PVP, Na and Ca salt of crosslinked carboxymethylcellulose, sodium salt of carboxymethyl starch, low-substituted hydroxypropylcellulose L-HPC) and essentially inorganic water-insoluble components (silicas, silicates, inorganic pigments) Commitment.
- the tablets may also contain surfactants.
- WO 2003/051338 describes a direct tabletting and readily compressible excipient formulation which contains mannitol and sorbitol.
- an auxiliary premix is prepared by dissolving mannitol and sorbitol in water followed by spray drying (ordinary spray drying and SBD). Mannitol can additionally be added to this coprocessed mixture. Tablets which additionally contain disintegrants, release agents, pigment and an active ingredient should disintegrate within 60 seconds in the oral cavity.
- a tablet which disintegrates within 60 seconds in the oral cavity and is mainly formulated from a physical mixture of spray-dried mannitol and a coarse cross-linked polyvinylpyrrolidone as well as a limited selection of active ingredients. These tablets have a breaking strength of about 40N and produce an unpleasant, sandy mouthfeel.
- a type C methacrylic acid copolymer is to be used as disintegrant.
- the methacrylic acid copolymer type C is a gastric juice-resistant polymer, which is not soluble in the acidic pH range, in the pH range of 7, as it is in the oral cavity, but is water-soluble.
- the tablets In addition to a low breaking strength ( ⁇ 20N), the tablets have a high friability (> 7%) and contain a high proportion in the range of
- EP 0839526 A2 describes a pharmaceutical dosage form consisting of an active ingredient, erythritol, crystalline cellulose and a disintegrant. Furthermore, mannitol is incorporated and crosslinked as disintegrants polyvinylpyrrolidone used, so that a physical mixture is formed. The tablets should disintegrate within 60 seconds in the oral cavity.
- a disintegrating in the mouth within 60 seconds tablet consisting of an active ingredient, a water-soluble polyvinyl alcohol-polyethylene glycol copolymer, sugar / sugar alcohol (mannitol) and disintegrants is described.
- WO 2007071581 describes preparations which consist of a sugar or sugar alcohol and cross-linked polyvinylpyrrolidone which are agglomerated with an aqueous dispersion of a water-insoluble polymer.
- a disadvantage of these preparations is that tablets produced therefrom undergo considerable prolongations of the disintegration time when stored at elevated temperature and elevated humidity.
- the preparations require relatively high amounts of lubricant in the tableting and they tend to stick to the punches.
- the object of the present invention was to find quickly disintegrating tablets in the mouth, which leave a pleasant mouthfeel, are mechanically very stable, experience no disintegration prolongations when stored at elevated humidity and temperature and show no tendency to stick in the tableting.
- rapidly disintegrating tablets containing such preparations were found in the mouth.
- the tablets disintegrate in the mouth or in an aqueous medium within 40 seconds, preferably within 30 seconds, more preferably within 20 seconds.
- a sugar or sugar alcohol is then called when an aqueous solution gives a film-like, smooth coating when dried at 45 ° C.
- Non-film-forming sugars or sugar alcohols show a powdery or crystalline structure after drying.
- the pharmaceutical preparations contain as component a) 60-96 wt .-% of at least one non-film forming sugar or sugar alcohol, more preferably 80 to 90 wt .-% non-film-forming sugars, sugar alcohols or mixtures thereof.
- non-film-forming sugars or sugar alcohols are mannitol, erythritol, or xylitol.
- the sugar or sugar alcohol components are preferably finely divided, with mean particle sizes of from 5 to 100 ⁇ m. preferably 10 to 80 ⁇ . If desired, the particle sizes can be adjusted by grinding.
- Mannitol, xylitol, erythritol or mixtures thereof are preferably used. Very particularly preferred is mannitol.
- Component b) used is 1 to 10% by weight of film-forming sugars or sugar alcohols, particularly preferably 2 to 6% by weight of film-forming sugars or sugar alcohols or mixtures thereof.
- the film-forming sugars or sugar alcohols include: sucrose, glucose, for example in the form of glucose syrup, fructose, lactose, trehalose, sorbitol, maltitol, lactitol, palatinit® (isomalt) and glucose syrup.
- a film-drawing device for example, is a commercial device such as the Coatmaster 509 MC.
- film-forming refers to the products that are present as a clear film or coating after the drying process.When crystals are visible or the mass appears powdery, the substances are classified as "non-film-forming". Accordingly, for example, a clear film / coating: sorbitol, lactitol maltitol, palatinite, lactose, sucrose, trehalose or glucose. Crystals or a powdery structure form, for example, mannitol, xylitol or erythritol.
- disintegrants in amounts of 3 to 25 wt .-%, preferably, 4 to 20 wt .-%, particularly preferably 5 to 15 wt .-%, are used.
- Suitable disintegrants are cross-linked polyvinylpyrrolidones, sodium croscarmellose, cross-linked Na-carboxymethyl starch or L-hydroxypropylcellulose (L-HPC).
- L-HPC is a low substituted hydroxypropyl cellulose with a degree of substitution of 5 to 16% (after drying for 1 h at 105 ° C). It is also possible to use mixtures of these disintegrating agents.
- Preferred disintegrants are cross-linked polyvinylpyrrolidones.
- Such crosslinked polyvinylpyrrolidones are water-insoluble (less than 1 part in 10,000 parts solvent), but not film-forming.
- the crosslinked polyvinylpyrrolidone may have an average particle size (volume average) of from 2 to 60 ⁇ m, preferably from 2 to less than 50 ⁇ m, particularly preferably from 2 to less than 30 ⁇ m.
- Very particular preference is given to cross-linked polyvinylpyrrolidones having a hydration capacity of greater than 6.5 g / g.
- the hydration capacity is determined by the following method:
- water-insoluble film-forming polymers in amounts of 0 to 10% by weight, preferably 0 to 6% by weight, particularly preferably 1 to 5% by weight, can be used as component d).
- the polymers should be film-forming polymers.
- film-forming means that the polymers in aqueous dispersion have a minimum film-forming temperature of -20 to + 150 ° C., preferably 0 to 100 ° C.
- Suitable polymers are polyvinyl acetate, ethyl cellulose, methyl methacrylate-ethyl acrylate copolymers, Ethylaci lat-methyl methacrylate-trimethylammoniumethyl methacrylate terpolymers, or Butylmethaci lat-methyl methacrylate-dimethylaminoethyl methacrylate terpolymers
- the acrylate-methacrylate copolymers are described in detail in the European Pharmacopoeia as Polyacrylate Dispersion 30%, in the USP as Ammonio Methacrylate Copolymer and in JPE as Aminoalkyl-Methacrylate Copolymer E.
- the preferred component d) is ethylcellulose.
- Suitable ethylcelluloses usually have an ethoxyl content of 45 to 50%.
- Such ethylcelluloses and also the determination of the ethoxyl content are described in various pharmacopoeias such as e.g. the USP 34 (201 1) described.
- the viscosity of the ethyl cellulose measured as a 5% strength by weight solution in toluene / ethanol 8: 2, is 3 to 400 mPas, preferably 4 to 200 and particularly preferably 5 to 100 mPas. The measurement is carried out at 25 ° C in a Ubbelohde viscometer.
- the taste and appearance of the tablets obtained from the formulations can be further improved by addition of pharmaceutically customary auxiliaries (components e) in amounts of from 0 to 15% by weight, for example as acidifiers, buffer substances, sweeteners, flavors, flavor enhancers and colorants ,
- auxiliaries for example as acidifiers, buffer substances, sweeteners, flavors, flavor enhancers and colorants .
- the following substances are particularly suitable here: citric acid, tartaric acid, ascorbic acid, sodium dihydrogen phosphate, cyclamate, saccharin sodium, aspartame, menthol, peppermint flavor, fruit flavors, vanilla flavor, glutamate, riboflavin, beta carotene, water-soluble dyes, finely divided lakes.
- Suitable substances are, for example, polyvinylpyrrolidones, vinylpyrrolidone-vinyl acetate copolymers, polyvinyl alcohols, polyvinyl alcohol-polyethylene glycol graft copolymers, polyethylene glycols, ethylene glycol-propylene glycol block copolymers, hydroxypropylmethylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, carragenans, pectins, xanthans, alginates.
- surfactants can also be added as components e).
- Suitable surfactants are, for example, sodium lauryl sulfate, dioctylsulfosuccinate, alkoxylated sorbitan esters such as polysorbate 80, polyalkoxylated derivatives of castor oil or hydrogenated castor oil, for example Cremophor® RH 40, alkoxylated fatty acids, alkoxylated hydroxyfatty acids, alkoxylated fatty alcohols, alkali metal salts of fatty acids and lecithins.
- finely divided pigments can be added to further improve the disintegration because they increase the internal interfaces and thus water can penetrate faster in the tablet.
- these pigments such as iron oxides, titanium dioxide, colloidal or precipitated silica, calcium carbonates, calcium phosphates must be very finely divided, otherwise a grainy taste is produced.
- the formulations according to the invention in the form of granules can be prepared by built-up agglomeration in mixers, fluidized bed apparatus, paddle dryers or spray towers. In this case, solid starting materials and granulation are first brought together and dried the moist material simultaneously or subsequently.
- the granulating liquid used is an aqueous solution of component b), the film-forming sugar or sugar alcohol.
- an aqueous solution of the powdered film-forming sugar or sugar alcohol which is a fluidized mixture of non-film forming sugar or sugar alcohol and crosslinked PVP, and optionally further polymers or adjuvants, is sprayed, thereby agglomerating the fine particles ,
- a disintegrant preferably crosslinked PVP, is suspended in the aqueous granulating liquid containing the film-forming sugars or sugar alcohols.
- insoluble film-forming polymer is suspended in the aqueous granulating liquid containing the film-forming sugars or sugar alcohols.
- a disintegrating agent preferably crosslinked PVP, and insoluble film-forming polymer are suspended.
- the so-called FSD or SBD fluidized spray drying
- a solution of the non-film-forming sugar or sugar alcohol in water is first spray-dried, in the lower part of the spray dryer or in a connected fluidized bed is the addition of crosslinked PVP and the injection of an aqueous solution of the film-forming sugar or sugar alcohol as a spray solution, whereby the particles agglomerate , Fine particles can also be blown again in front of the spray nozzle of the sugar or sugar alcohol solution and additionally agglomerated.
- FSD or SBD process control starting from the crystalline form of non-film-forming sugar or non-film-forming sugar alcohol.
- the crystalline sugar or sugar alcohol is added at the top of the spray tower or in the fine material recycling stream.
- the crystalline solid of the non-film-forming sugar (alcohol) is agglomerated in the tower to give granules.
- the spray-drying of the non-film-forming sugar (alcohol) s usually takes place from aqueous solutions with a concentration of 10 to 50 wt .-%.
- the film-forming sugar alcohol is usually used in the form of aqueous solutions with a concentration of 1 to 40 wt .-%.
- the concentration of the film-forming sugar alcohol in the aqueous spray solution can also be varied in two or more process steps.
- a relative exhaust air humidity of greater than 85% is set by adjusting the spray rate, the supply air temperature, the supply air volume and the humidity of the supply air.
- the two main parameters are the spray rate and the supply air temperature. An increase in the spray rate and a reduction in the supply air temperature lead to an increase in the exhaust air humidity.
- the spray rate can be selected in the range of 3 g to 35 g per minute per kg of powder, preferably 5 g to 30 g per minute per kg of powder.
- the supply air temperatures are 20 to 80 ° C, preferably 30 to 60 ° C.
- the exhaust air temperatures are 10 to 60 ° C, preferably 10 to 40 ° C and particularly preferably 15 to 30 ° C.
- the granulation is preferably carried out at a spray rate of 5 g to 30 g per minute per kg Pulvervor- läge in combination with a supply air temperature of 30 to 60 ° C and an exhaust air temperature of 10 to 40 ° C.
- the granulation is carried out at a spray rate of 6 g to 18 g per minute per kg powder template in combination with a supply air temperature of 35 to 50 ° C and an exhaust air temperature of 15 to 25 ° C.
- the supply air humidity can be up to 99.5% r.F. be.
- the concentration of the aqueous spray solution of the film-forming sugar or sugar alcohol is varied in several steps. Initially, the concentration is kept very low - it may even be 0% by weight (spraying water) - to humidify the submitted materials and to set a high exhaust air humidity. This does not involve agglomeration into granules. Thereafter, the concentration of the aqueous spray solution of the film-forming sugar or sugar alcohol is increased, whereby the submitted materials agglomerate into granules. In the individual stages, the process conditions can be varied within the given limits.
- the mass ratio of the spray solutions of the first and second stages may be varied from 1 to 5 to 5 to 1, preferably 1 to 2 to 2 to 1.
- the granule size can be controlled by the amount of film-forming sugar or sugar alcohol in the product. The more of this substance is introduced, the larger the granules.
- the fineness of the spray droplet of the binder solution (adjustable via the atomizing gas pressure), the nozzle geometry and the distance of the nozzle from the product bed can be considered.
- the finer and more uniformly sprayed, the finer and more uniform the granules result.
- the atomization gas pressure is usually in the range from 0.5 to 5 bar, preferably from 1.0 to 3.0 bar.
- nozzles usually two-fluid nozzles are used.
- the nozzle diameters are usually in the range of 0.5 to 4.0 mm, preferably 0.8 to 3.0 mm.
- the distance of the nozzles from the product bed depends on the size of the atomizer. Which distances are suitable in the individual case can be determined by the person skilled in the art by means of a few customary tests.
- the moist material is dried.
- the intake air temperature is increased in order to accelerate the drying process. Typical temperatures are 30-100 ° C.
- the materials submitted are sprayed with a solution of the film-forming sugar or sugar alcohol in water and dried simultaneously or subsequently.
- the granules can also be prepared in a mixer by means of a continuously guided mixture aggregation.
- a continuously guided mixture aggregation is the so-called “Schugi granulation.”
- Solid starting materials and the granulating liquid containing the film-forming sugar or sugar alcohol are intensively mixed in a continuously operating, vertically arranged high-speed mixer (see also M. Bohnet, "Mechanical Process Engineering”). , Wiley VCH Verlag, Weinheim 2004, p. 198 ff.)
- the granules thus obtained have an average particle size (volume average) of 100-600 ⁇ , preferably 120-500 ⁇ and particularly preferably 140-400 ⁇ on.
- the film-forming sugar or sugar alcohol serves as an agglomerating agent to agglomerate the fine non-film-forming sugars or sugar alcohol crystals and the particles of crosslinked PVP.
- the granules according to the invention can be tabletted with small amounts of lubricant, which results in no significant influence on the disintegration time. Furthermore, the granules according to the invention do not stick to the punches, whereby higher tabletting speeds and shorter tableting processes are achieved.
- the formulations according to the invention are preferably suitable for the preparation of tablets rapidly disintegrating in the mouth.
- the formulations according to the invention can advantageously also be used for the production of tablets which are allowed to disintegrate in a glass of water before use.
- the production of tablets, which are swallowed intact, is of course possible.
- the usual methods can be used, wherein the direct tabletting and roll compaction offer particular advantages. Due to the special properties of the formulations according to the invention, generally only the active ingredient, the formulation according to the invention and a lubricant are required.
- the tablet formulation is thus very simple, very reproducible and easy to validate the procedure.
- a film-forming sugar or sugar alcohol can function as a very effective binder with appropriate process control, which also significantly accelerates the disintegration of tablets.
- the production of granules is possible which contain neither a water-soluble polymer nor a water-insoluble polymer as a binder.
- the use of water-soluble polymers leads to significantly longer disintegration times of tablets, and the use of water-insoluble polymers gives rise to quickly disintegrating tablets, which, however, exhibit considerable disintegration prolongations when stored at elevated temperature and / or elevated humidity.
- the disintegration time of the preparations according to the invention is not influenced by increased temperature and humidity.
- the preparations according to the invention have exceptionally good flowability and compressibility, which lead to very stable tablets.
- the breaking strength of the tablets produced with the aid of the pharmaceutical formulations according to the invention is> 50 N. Frequently, the breaking strengths are above 80 N, even when using difficult to press active ingredients.
- the friability is ⁇ 0.2%. Damage to the usual tablet handling thus does not occur. Due to the fine cross-linked polyvinylpyrrolidone, the tablets show almost no changes in the tablet surface upon moist storage. In contrast to coarse cross-linked polyvinylpyrrolidone, there is no pilling due to highly swollen particles. The formulations according to the invention are thus very stable on storage and retain their attractive appearance.
- Examples A-H show the agglomerating effect of film-forming sugars or sugar alcohols.
- Non-film-forming sugar / sugar alcohol and cross-linked PVP and other auxiliaries were introduced in a fluidized bed and with a 3 wt .-% aqueous solution of film-forming sugar or sugar alcohol, in the fluidized bed granulator (Glatt, GPCG 3.1) by top spray method were sprayed, agglomerated.
- Table 1 Formulation composition of granules A to H in% by weight AB c DEFGHI
- Kollicoat® MAE 100 P powder, 97% by weight of methacrylic acid-ethyl acrylate copolymer (1: 1), 2.3% by weight of polysorbate 80, 0.7% by weight of sodium lauryl sulfate
- Ethyl cellulose 7 mPas, ethoxyl content 48.0 - 49.5%
- Kollicoat® IR Graft copolymer of 25% by weight of PEG6000 and 75% by weight of polyvinyl alcohol side chains, MW 45,000 D.
- the granules produced had the following properties: Mean particles
- the particle size was determined by light diffraction and used as average particle size (volume average) of the D (4,3) value.
- the granules thus prepared were mixed with 2.0% by weight of lubricant (sodium stearyl fumarate) in a Turbula mixer for 5 minutes. Subsequently, these mixtures were tabletted on a fully instrumented rotary tablet press (Korsch XL 100/8) at a speed of 40 rpm.
- the rotary tablet press was equipped with 8 punches (10 mm, biplan, faceted). The tablet weight was adjusted to 300 mg. The pressing force was adjusted so that the breaking strength of the tablets was 50 N.
- the tablets were tested for breaking strength (tablet tester HT-TMB-CI-12 F, Messrs. Kraemer), friability (Roche Friabilator, Erweka) and disintegration time in phosphate buffer pH 7.2 (disintegration tester ZT 74, Erweka).
- the preparation was carried out analogously to Example B, but instead of a sorbitol solution, a xylitol solution was used.
- Example B The preparation was carried out analogously to Example B, but the spray rate was adjusted so that a relative exhaust air humidity of 70% resulted.
- Example L (Comparative Example to Example H of WO 2007/071581)
- the disintegration time of the tablets directly after preparation was 30 s.
- the tablets were then stored at 40 ° C./75% RH and at 60 ° C. for 4 weeks.
- the disintegration time increased to 180s or 204s. Examples M - P
- Examples M to P show the suitability of a fast disintegrating excipient in a drug formulation.
- the rapidly disintegrating excipient is prepared by agglomeration in the fluidized bed analogously to Example C.
- the direct tabletting agent thus prepared was mixed with active ingredient and 0.5 to 1.0% by weight of lubricant (Mg stearate) and then pressed on a rotary tablet press (Korsch PH 100/6) into tablets having a breaking strength of 50 N.
- Table 3 Active ingredient, amount of active ingredient, tablet weight and diameter of the active ingredient formulations M - P
- the tablets were tested for breaking strength (tablet tester HT-TMB-CI-12 F, Messrs. Kraemer), friability (Roche Friabilator, Erweka) and disintegration time in phosphate buffer pH 7.2 (disintegration tester ZT 74, Erweka).
- Non-film-forming sugar / sugar alcohol and crosslinked PVP and other auxiliaries were introduced in a fluidized bed and first with demineralized water and then with a 6 wt .-% aqueous solution of the film-forming sugar or sugar alcohol in the fluidized bed granulator (Glatt, GPCG 3.1) sprayed by topspray method, agglomerated.
- the following manufacturing conditions were used:
- Table 1 Formulation composition of the granules Q to S in% by weight
- the particle size was determined by means of light diffraction and used as average particle size (volume average) of the D (4,3) value.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR112013022017A BR112013022017A2 (en) | 2011-03-09 | 2012-03-06 | pharmaceutical formulation, tablet, and method for producing a pharmaceutical formulation |
| EP12706862.5A EP2683365A1 (en) | 2011-03-09 | 2012-03-06 | Pharmaceutical formulation for producing rapidly disintegrating tablets |
| CN201280012068.0A CN103415284B (en) | 2011-03-09 | 2012-03-06 | Pharmaceutical formulation for producing rapidly disintegrating tablets |
| JP2013557067A JP2014507454A (en) | 2011-03-09 | 2012-03-06 | Pharmaceutical formulation for manufacturing fast-disintegrating tablets |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11157458.8 | 2011-03-09 | ||
| EP11157458 | 2011-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2012119997A1 true WO2012119997A1 (en) | 2012-09-13 |
Family
ID=45787220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2012/053771 WO2012119997A1 (en) | 2011-03-09 | 2012-03-06 | Pharmaceutical formulation for producing rapidly disintegrating tablets |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2683365A1 (en) |
| JP (1) | JP2014507454A (en) |
| CN (1) | CN103415284B (en) |
| BR (1) | BR112013022017A2 (en) |
| WO (1) | WO2012119997A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023099532A1 (en) * | 2021-12-02 | 2023-06-08 | Basf Se | Direct tableting auxiliary composition |
| US12031128B2 (en) | 2021-04-07 | 2024-07-09 | Battelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| US12109223B2 (en) | 2020-12-03 | 2024-10-08 | Battelle Memorial Institute | Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery |
| US12441996B2 (en) | 2024-12-06 | 2025-10-14 | Battelle Memorial Institute | Use of DNA origami nanostructures for molecular information based data storage systems |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19615418A1 (en) * | 1996-04-22 | 1997-10-23 | Merck Patent Gmbh | Polyol composition |
| EP0839526A2 (en) | 1996-10-31 | 1998-05-06 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
| US20020071864A1 (en) | 1999-03-25 | 2002-06-13 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
| WO2003051338A1 (en) | 2001-12-17 | 2003-06-26 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
| US6696085B2 (en) | 1998-07-20 | 2004-02-24 | Antares Pharma Ipl Ag | Use of an acrylic type polymer as disintegrating agent |
| JP2004265216A (en) | 2003-03-03 | 2004-09-24 | Seiko Epson Corp | Printing apparatus, receiving apparatus, relay apparatus, printing system, and printing method |
| CN1732905A (en) * | 2004-08-09 | 2006-02-15 | 赵力 | Directly tabletting xylitol powder and its production method |
| WO2007071581A2 (en) | 2005-12-21 | 2007-06-28 | Basf Se | Pharmaceutical formulation for producing rapidly disintegrating tablets |
| EP1852109A1 (en) * | 2005-05-08 | 2007-11-07 | Beijing Jianli Pharmaceutical Co. Ltd. | Xylitol granules capable of directly being pressed into tablets and preparation process thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1020380A (en) * | 1996-07-05 | 1998-01-23 | Minolta Co Ltd | Camera |
| EP1674083B1 (en) * | 2003-10-15 | 2018-08-01 | Fuji Chemical Industry Co., Ltd. | Tablet quickly disintegrating in oral cavity |
| CN101360480B (en) * | 2005-12-21 | 2015-04-08 | 巴斯夫欧洲公司 | Pharmaceutical formulation for producing rapidly disintegrating tablets |
| CN101677945A (en) * | 2007-05-08 | 2010-03-24 | 赫尔克里士公司 | Robust rapid disintegration tablet formulation |
| JP5420535B2 (en) * | 2007-06-06 | 2014-02-19 | ビーエーエスエフ ソシエタス・ヨーロピア | Pharmaceutical formulations for the production of fast-disintegrating tablets |
-
2012
- 2012-03-06 WO PCT/EP2012/053771 patent/WO2012119997A1/en active Application Filing
- 2012-03-06 CN CN201280012068.0A patent/CN103415284B/en not_active Expired - Fee Related
- 2012-03-06 JP JP2013557067A patent/JP2014507454A/en not_active Ceased
- 2012-03-06 EP EP12706862.5A patent/EP2683365A1/en not_active Withdrawn
- 2012-03-06 BR BR112013022017A patent/BR112013022017A2/en not_active IP Right Cessation
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19615418A1 (en) * | 1996-04-22 | 1997-10-23 | Merck Patent Gmbh | Polyol composition |
| EP0839526A2 (en) | 1996-10-31 | 1998-05-06 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
| US6696085B2 (en) | 1998-07-20 | 2004-02-24 | Antares Pharma Ipl Ag | Use of an acrylic type polymer as disintegrating agent |
| US20020071864A1 (en) | 1999-03-25 | 2002-06-13 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
| WO2003051338A1 (en) | 2001-12-17 | 2003-06-26 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
| JP2004265216A (en) | 2003-03-03 | 2004-09-24 | Seiko Epson Corp | Printing apparatus, receiving apparatus, relay apparatus, printing system, and printing method |
| CN1732905A (en) * | 2004-08-09 | 2006-02-15 | 赵力 | Directly tabletting xylitol powder and its production method |
| EP1852109A1 (en) * | 2005-05-08 | 2007-11-07 | Beijing Jianli Pharmaceutical Co. Ltd. | Xylitol granules capable of directly being pressed into tablets and preparation process thereof |
| WO2007071581A2 (en) | 2005-12-21 | 2007-06-28 | Basf Se | Pharmaceutical formulation for producing rapidly disintegrating tablets |
Non-Patent Citations (1)
| Title |
|---|
| M. BOHNET: "Mechanische Verfahrenstechnik", 2004, WILEY VCH VERLAG, pages: 198 FF |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12109223B2 (en) | 2020-12-03 | 2024-10-08 | Battelle Memorial Institute | Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery |
| US12433910B2 (en) | 2020-12-03 | 2025-10-07 | Battelle Memorial Institute | Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery |
| US12031128B2 (en) | 2021-04-07 | 2024-07-09 | Battelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| WO2023099532A1 (en) * | 2021-12-02 | 2023-06-08 | Basf Se | Direct tableting auxiliary composition |
| US12441996B2 (en) | 2024-12-06 | 2025-10-14 | Battelle Memorial Institute | Use of DNA origami nanostructures for molecular information based data storage systems |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2683365A1 (en) | 2014-01-15 |
| JP2014507454A (en) | 2014-03-27 |
| BR112013022017A2 (en) | 2016-11-29 |
| CN103415284B (en) | 2016-12-07 |
| CN103415284A (en) | 2013-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1965761B1 (en) | Pharmaceutical formulation for producing rapidly disintegrating tablets | |
| EP2164462B1 (en) | Pharmaceutical formulation for the production of rapidly disintegrating tablets | |
| EP2170273B1 (en) | Pharmaceutical formulation for the production of rapidly disintegrating tablets | |
| EP2164461B1 (en) | Chewable tablets and lozenges | |
| DE69933689T2 (en) | PROCESS FOR PREPARING ORAL CALCIUM COMPOSITIONS | |
| WO2016015812A1 (en) | Directly compressible polyvinyl alcohols | |
| WO2016015813A1 (en) | Directly compressible composition containing micro-crystalline cellulose | |
| EP2164460B1 (en) | Pharmaceutical formulation for the production of rapidly disintegrating tablets | |
| EP2259778A2 (en) | Mixture for producing rapidly disintegrating tablets | |
| WO2006092222A1 (en) | Medicament forms with controlled bioavailability | |
| WO2012119997A1 (en) | Pharmaceutical formulation for producing rapidly disintegrating tablets | |
| WO2009037114A1 (en) | Medium for the treatment of mouth and throat in the form of tablets | |
| US20120231042A1 (en) | Pharmaceutical Formulation For Producing Rapidly Disintegrating Tablets | |
| WO2004069132A2 (en) | Pharmaceutical preparations and a method for their production | |
| EP2039255A1 (en) | Formulae for dietary supplements and solid sweet luxury foodstuffs which dissolve in the mouth |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12706862 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2012706862 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2013557067 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013022017 Country of ref document: BR |
|
| ENP | Entry into the national phase |
Ref document number: 112013022017 Country of ref document: BR Kind code of ref document: A2 Effective date: 20130828 |